Zydus receives USFDA EIR for Baddi facility
- 30 October 2025
- 2 days ago
FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension
- 29 October 2025
- 3 days ago
FDA Approves Obinutuzumab for Active Lupus Nephritis
- 29 October 2025
- 3 days ago
Alembic Pharma wins USFDA nod for heart disease drug
- 29 October 2025
- 3 days ago
Granules India gets USFDA EIR for Bonthapally facility
- 29 October 2025
- 3 days ago
USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension
- 28 October 2025
- 4 days ago
Cohance Lifesciences Nacharam facility gets OAI status from USFDA
- 27 October 2025
- 5 days ago
Recent News
SR Post VACANCIES At ESIC Model Hospital Noida, Ch...
- 02 November, 2025
Pathologist's signature on medical reports not mus...
- 02 November, 2025
UP Eyes Japanese Investment: 125 Pharma Giants Inv...
- 02 November, 2025
Delhi Govt to recruit 1,593 senior resident doctor...
- 02 November, 2025
Former Drug Inspector's Office Clerk Jailed for Ta...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









